Show simple item record

AuthorGeneralova, Daria
AuthorCunningham, Scott
AuthorLeslie, Stephen J
AuthorRushworth, Gordon F
AuthorMciver, Laura
AuthorStewart, Derek
Available date2020-07-06T11:15:29Z
Publication Date2020-06-01
Publication NamePharmacy Practice
Identifierhttp://dx.doi.org/10.18549/PharmPract.2020.2.1936
CitationGeneralova D, Cunningham S, Leslie SJ, Rushworth GF, McIver L, Stewart D. Prescribers’ perceptions of benefits and limitations of direct acting oral anticoagulants in non-valvular atrial fibrillation. Pharm Pract (Granada) [Internet]. 2020Jun.13 [cited 2020Jul.6];18(2):1936. Available from: https://www.pharmacypractice.org/journal/index.php/pp/article/view/1936
ISSN1886-3655
URIhttp://hdl.handle.net/10576/15156
AbstractThere is an acknowledged lack of robust and rigorous research focusing on the perspectives of those prescribing direct acting oral anticoagulants (DOACs) for non-valvular atrial fibrillation (AF). The objective was to describe prescribers' experiences of using DOACs in the management of non-valvular AF, including perceptions of benefits and limitations. A cross-sectional survey of prescribers in a remote and rural area of Scotland. Among other items, the questionnaire invited free-text description of positive and negative experiences of DOACs, and benefits and limitations. Responses were independently analysed by two researchers using a summative content analysis approach. This involved counting and comparison, via keywords and content, followed by interpretation and coding of the underlying context into themes. One hundred and fifty-four responses were received, 120 (77.9%) from physicians, 18 (11.7%) from nurse prescribers and 10 (6.4%) from pharmacist prescribers (6 unidentified professions). Not having to monitor INR was the most cited benefit, particularly for prescribers and patients in remote and rural settings, followed by potentially improved patient adherence. These benefits were reflected in respondents' descriptions of positive experiences and patient feedback. The main limitations were the lack of reversal agents, cost and inability to monitor anticoagulation status. Many described their experiences of adverse effects of DOACs including fatal and non-fatal bleeding, and upper gastrointestinal disturbances. While prescribers have positive experiences and perceive benefits of DOACs, issues such as adverse effects and inability to monitor anticoagulation status merit further monitoring and investigation. These issues are particularly relevant given the trajectory of increased prescribing of DOACs.
Languageen
PublisherCentro de Investigaciones y Publicaciones Farmaceuticas
SubjectAtrial Fibrillation
Attitude of Health Personnel
Cross-Sectional Studies
Drug Prescriptions
Factor Xa Inhibitors
Health Knowledge, Attitudes, Practice
Scotland
TitlePrescribers' perceptions of benefits and limitations of direct acting oral anticoagulants in non-valvular atrial fibrillation.
TypeArticle
Issue Number2
Volume Number12
ESSN1885-642X
dc.accessType Open Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record